Hypothesis

Telomere length in colonic epithelium operates as an entropy‑sensing clock that predicts the velocity of tight‑junction (TJ) protein loss and downstream inflammaging, independent of mitotic history.

Rationale

Recent work shows age‑dependent decline of ZO‑1, occludin and JAM‑A in the primate gut, driving permeability‑mediated endotoxemia and inflammaging [1][2]. Oxidative stress and NLRP3 activation directly damage TJ complexes [5]. If telomeres quantify informational entropy rather than division count, then accelerated telomere attrition should mirror rising molecular disorder in epithelial cells, precipitating TJ gene dysregulation before any detectable change in proliferation markers.

Mechanistic Extension

1. Entropy‑driven chromatin destabilization – Shortened telomeres increase local heterochromatin loss, releasing repressive marks from TJ gene promoters (ZO‑1, occludin, JAM‑A). This transcriptional silencing occurs even when Ki‑67 indices are low, linking telomere entropy directly to barrier gene expression.
2. Telomere damage‑induced SASP – Persistent telomere‑associated DNA foci activate ATM‑p53 pathways, provoking a senescence‑associated secretory phenotype rich in IL‑1α, IL‑6 and MMPs. These factors phosphorylate myosin light chain kinase (MLCK), augmenting actomyosin contractility and physically pulling TJ strands apart [5] [6]
3. Feedback amplification – Barrier breach elevates luminal LPS, boosting hepatic LBP and systemic TLR4 signaling, which further augments ROS production in epithelium, accelerating telomere erosion—a self‑reinforcing loop.

Testable Predictions

• Prediction 1: In longitudinal colonic biopsies from aged non‑human primates, the rate of telomere shortening per year (measured by quantitative FISH or qPCR) will correlate negatively with the slope of ZO‑1/occludin fluorescence intensity loss, after adjusting for cellular proliferation (Ki‑67).
• Prediction 2: Animals exhibiting rapid telomere attrition will show earlier and greater increases in circulating LBP, IL‑6 and TNF‑α compared with slow‑attrition peers, despite similar chronological age.
• Prediction 3: Pharmacological reduction of epithelial oxidative stress (e.g., Nrf2 activator sulforaphane) will decelerate telomere shortening, preserve TJ protein expression, and attenuate LBP elevation over a 12‑month period.

Experimental Approach

1. Cohort of 30 aged macaques (≥18 years) receive serial colonoscopic biopsies every 4 months for 2 years.
2. Each sample undergoes:
   • Telomere length assay (Q‑FISH on epithelial nuclei)
   • Immunofluorescence quantification of apical ZO‑1, occludin, JAM‑A
   • Ki‑67 staining to index proliferation
   • ROS detection (DHE fluorescence)
3. Plasma collected at each time point for LBP, LPS, IL‑6, TNF‑α.
4. Intervention subgroup (n=10) receives sulforaphane; control subgroup receives vehicle.
5. Statistical analysis uses mixed‑effects models to test whether telomere shortening rate predicts TJ decline velocity and inflammaging markers, controlling for baseline telomere length and proliferation.

Falsifiability

If telomere length merely reflects division count, then after accounting for Ki‑67, telomere attrition will show no independent association with TJ loss or inflammaging. Likewise, antioxidant intervention failing to alter telomere dynamics or barrier integrity would refute the entropy‑clock mechanism.

This hypothesis directly links an information‑theoretic view of telomeres to the kinetics of gut barrier failure, offering a novel biomarker and therapeutic target for inflammaging.